September 17th 2025
In addition to the proxy statement, STAAR has reached out to all stockholders to ask for their vote to adopt the merger agreement.
September 17th 2025
DRCR.net retinal treatment results take center stage in 2015
December 1st 2015Studies of the efficacy of anti-vascular endothelial growth factor (VEGF), gene therapies, and slow-release drug delivery systems took center stage among treatments for retinal disorders in 2015. In addition to studies already under way, others are about to begin.
Bone marrow cells show promise in degenerative, ischemic retinal diseases
June 15th 2015The safety and feasibility of intravitreal autologous CD34+ bone marrow cells as a potential therapy for retinal disease were evaluated in a pilot study. Preliminary findings demonstrated the treatment was feasible and researchers intend to pursue a larger, prospective study with longer follow-up.
Pars plana vitrectomy makes paradigm shift for retinal surgery in Europe
June 15th 2015European retinal surgeons have been shifting to the use of pars plana vitrectomy for the repair of rhegmatogenous retinal detachment, but scleral buckle surgery is still a viable choice in young and uncomplicated cases.
Nitrosative & oxidative stress is associated with structural changes
June 10th 2015In this article, the authors present their recent study results. The study findings demonstrated, for the first time, that in vivo structural changes in ISel band and RPE are associated with increased plasma nitrosative and oxidative stress.
Retinal vein occlusion treatment undergoes paradigm shift with pharmacotherapy
November 1st 2014Based on findings from a series of clinical trials in recent years, pharmacotherapy has supplanted both laser photocoagulation and a watchful waiting approach as the first-line therapy for retinal vein occlusion.
Jackson Memorial Lecture: Past, present and future outlook of retinoblastoma
October 19th 2014“Retinoblastoma is a remarkable ophthalmology success story in which the efforts of ophthalmologists, ophthalmic pathologists, and research scientists have led to understanding of the basic mechanisms of cancer and targeted therapies that are able to cure a once incurable tumor,” said Hans E. Grossniklaus, MD, MBA. He was honored as the recipient of the 71st Jackson Memorial Lecture Award in the opening session of the annual meeting of the American Academy of Ophthalmology.